Calton & Associates, Inc. Omeros Corp Transaction History

Calton & Associates, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	SELL	$1.75 - $3.96 $82 - $186	-47 Reduced 0.32%	14,694 $0
Q3 2022 Oct 31, 2022	SELL	$3.09 - $7.46 $1,093 - $2,640	-354 Reduced 2.35%	14,741 $46,000
Q2 2022 Jul 12, 2022	SELL	$1.92 - $6.28 $1,524 - $4,986	-794 Reduced 5.0%	15,095 $41,000
Q1 2022 Apr 12, 2022	BUY	$5.07 - $7.2 $9,055 - $12,859	1,786 Added 12.66%	15,889 $95,000
Q4 2021 Jan 13, 2022	SELL	$5.67 - $8.54 $1,513 - $2,280	-267 Reduced 1.86%	14,103 $90,000
Q3 2021 Nov 05, 2021	SELL	$13.4 - $16.3 $1,112 - $1,352	-83 Reduced 0.57%	14,370 $198,000
Q2 2021 Aug 11, 2021	SELL	$14.81 - $19.13 $5,094 - $6,580	-344 Reduced 2.32%	14,453 $214,000
Q1 2021 May 03, 2021	SELL	$14.52 - $23.53 $130 - $211	-9 Reduced 0.06%	14,797 $263,000
Q4 2020 Jan 25, 2021	BUY	$10.14 - $15.19 $15,787 - $23,650	1,557 Added 11.75%	14,806 $212,000
Q3 2020 Oct 30, 2020	SELL	$9.57 - $21.32 $12,527 - $27,907	-1,309 Reduced 8.99%	13,249 $134,000
Q2 2020 Aug 10, 2020	SELL	$12.21 - $16.99 $634 - $883	-52 Reduced 0.36%	14,558 $214,000
Q1 2020 Apr 30, 2020	BUY	$9.03 - $19.72 $30,729 - $67,107	3,403 Added 30.36%	14,610 $195,000
Q4 2019 Feb 03, 2020	BUY	$13.01 - $17.15 $3,681 - $4,853	283 Added 2.59%	11,207 $158,000
Q3 2019 Nov 07, 2019	BUY	$14.55 - $20.56 $158,944 - $224,597	10,924 New	10,924 $178,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.